Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
2022 · PLoS Medicine · 151 citations
https://doi.org/10.1371/journal.pmed.1003992
R
Rebecca Legarth
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
1.2K
Citations
17
h-index
19
i10-index
Rebecca Legarth is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & SARS-CoV-2 detection and testing & COVID-19 Clinical Research Studies. The author has an h-index of 17, co-authored 25 publications.
Papers by this author
worksObserved protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
2022 · The Lancet Regional Health - Europe · 53 citations
https://doi.org/10.1016/j.lanepe.2022.100452
Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic
2022 · BMC Public Health · 26 citations
https://doi.org/10.1186/s12889-022-13694-9
Cryptococcal rib osteomyelitis as primary and only symptom of idiopathic CD4 penia
2014 · Medical Mycology Case Reports · 20 citations
https://doi.org/10.1016/j.mmcr.2014.02.002
When schools were open for in-person teaching during the COVID-19 pandemic - the nordic experience on control measures and transmission in schools during the delta wave
2023 · BMC Public Health · 9 citations
https://doi.org/10.1186/s12889-022-14906-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat